In Depth 29 Nov 2016 The ABCs of ADCs: A Review of Antibody Drug Conjugates Antibody therapies have a little sister who is catching up in funding – and hype? In light of now five deaths from Juno’s CAR-T therapy, antibody drug conjugates are attracting… November 29, 2016 - 8 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
Best in Biotech 14 Nov 2024 8 biotech companies advancing new treatments for breast cancer in 2024 …BioNTech Lead candidate in breast cancer: BNT323 in phase 3 Technology: ADC Recent news: FDA hold lifted for another cancer candidate, BNT326/YL202 Based in Mainz, Germany, BioNtech is a public… November 14, 2024 - 12 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 13 May 2025 Nine biotech companies in Montreal to keep an eye on in 2025 …multispecific antibodies for cancer and autoimmune diseases. It has four candidates – Leap 1009 and Leap 1030 for autoimmune diseases, and Leap 1121 and an undisclosed candidate to treat cancer,… May 13, 2025 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 4 Oct 2022 Absolute Biotech launches as unified antibody company …well as custom antibody sequencing, antibody engineering and recombinant antibody expression services. Brands within the Absolute Biotech family are: Absolute Antibody, LSBio, Kerafast, Nordic-MUbio, Everest Biotech, and Exalpha. Absolute Biotech… October 4, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Interview 8 Jun 2017 Cambridge Antibody Technology: The History of the UK’s Best Biotech …1989. The company, Cambridge Antibody Technology (CAT), would go on to be the biggest success story in UK biotech after its team discovered the blockbuster therapeutic antibody, Humira, and became… June 8, 2017 - 7 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
In Depth 10 Feb 2025 Monoclonal antibodies: are they the key to treating Alzheimer’s disease? …of contents Can monoclonal antibody remternetug prevent Alzheimer’s disease? A monoclonal antibody is a protein that binds to specific targets in the body. In the case of Alzheimer’s disease, these… February 10, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 10 Jun 2025 Pushing biotech forward in France: 18 companies to know about …broader applicability. Enterome recently presented positive interim results for the phase 2 of its lead candidate, EO2463. The candidate showed a 60% complete response rate in indolent non-Hodgkin’s lymphoma for… June 10, 2025 - 16 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 16 May 2025 Nine promising small molecule drug discovery companies to look out for in 2025 …company will use the proceeds to advance its current crop of candidates. 858 Therapeutics Disease areas: Oncology and immunology Lead candidate: ETX-19477 Recent news: Entered into a collaboration with OpenBench… May 16, 2025 - 13 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 14 Oct 2024 Six biomimicry biotech companies harnessing nature’s wisdom to develop breakthrough drug candidates …candidate of Bioxodes: BIOX-101 for hemorrhagic stroke Photo credits: Erik Karits Bioxodes is developing a first-in-class drug candidate for the prevention of thrombosis and neuroinflammation in patients with spontaneous intracerebral… October 14, 2024 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 29 Aug 2023 Are these 10 biotech recruiters on your radar this year? …their candidates, these biotech recruiters are said to be successful at attracting passive candidates who may be employed but are open to new opportunities. Labiotech has created a list of… August 29, 2023 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Interview 15 May 2017 Meet the CEO developing the Next Generation of Antibody Therapeutics Crescendo Biologics has positioned itself as the successor of Cambridge Antibody Technology and a new rival to Morphosys. We interviewed CEO Peter Pack. Peter Pack started working in life science… May 15, 2017 - 8 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 7 May 2025 Top biotech deals of April 2025 …company will be centered on. Furthermore, U.K.-based Epsilogen’s takeover of Massachusetts-based TigaTx will combine IgA antibody assets to pioneer new antibody therapeutics to address cancer. The acquisition is bound to… May 7, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email